NEVRO CORP's ticker is NVRO and the CUSIP is 64157F103. A total of 138 filers reported holding NEVRO CORP in Q3 2023. The put-call ratio across all filers is 2.46 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $12,628 | +1242.0% | 657 | +1675.7% | 0.00% | – |
Q2 2023 | $941 | -93.4% | 37 | -90.6% | 0.00% | -100.0% |
Q1 2023 | $14,280 | +89.8% | 395 | +107.9% | 0.00% | 0.0% |
Q4 2022 | $7,524 | -65.8% | 190 | -59.2% | 0.00% | -66.7% |
Q3 2022 | $22,000 | +46.7% | 466 | +40.8% | 0.00% | +50.0% |
Q2 2022 | $15,000 | +7.1% | 331 | +68.0% | 0.00% | 0.0% |
Q1 2022 | $14,000 | -53.3% | 197 | -46.5% | 0.00% | -50.0% |
Q4 2021 | $30,000 | +25.0% | 368 | +79.5% | 0.00% | +33.3% |
Q3 2021 | $24,000 | -14.3% | 205 | +20.6% | 0.00% | -25.0% |
Q2 2021 | $28,000 | 0.0% | 170 | -14.6% | 0.00% | -20.0% |
Q1 2021 | $28,000 | -3.4% | 199 | +17.1% | 0.01% | 0.0% |
Q4 2020 | $29,000 | +20.8% | 170 | 0.0% | 0.01% | 0.0% |
Q3 2020 | $24,000 | +20.0% | 170 | 0.0% | 0.01% | +25.0% |
Q2 2020 | $20,000 | +17.6% | 170 | +1.8% | 0.00% | +33.3% |
Q1 2020 | $17,000 | -10.5% | 167 | 0.0% | 0.00% | +50.0% |
Q4 2019 | $19,000 | +35.7% | 167 | 0.0% | 0.00% | 0.0% |
Q3 2019 | $14,000 | +40.0% | 167 | 0.0% | 0.00% | 0.0% |
Q2 2019 | $10,000 | 0.0% | 167 | 0.0% | 0.00% | 0.0% |
Q1 2019 | $10,000 | +66.7% | 167 | 0.0% | 0.00% | 0.0% |
Q4 2018 | $6,000 | -14.3% | 167 | +75.8% | 0.00% | 0.0% |
Q2 2018 | $7,000 | -12.5% | 95 | 0.0% | 0.00% | -33.3% |
Q1 2018 | $8,000 | – | 95 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Tiger Eye Capital LLC | 239,122 | $41,392,000 | 8.25% |
Integral Health Asset Management, LLC | 88,000 | $15,233,000 | 4.53% |
Iron Triangle Partners LP | 168,761 | $29,213,000 | 3.79% |
Eos Focused Equity Management, L.P. | 14,002 | $2,424,000 | 2.37% |
PFM Health Sciences, LP | 311,940 | $53,997,000 | 1.90% |
Perceptive Advisors | 977,565 | $169,217,000 | 1.82% |
Rock Springs Capital Management LP | 395,000 | $68,375,000 | 1.45% |
Lisanti Capital Growth, LLC | 54,302 | $9,400,000 | 1.30% |
HealthCor Management, L.P. | 156,046 | $27,012,000 | 1.04% |
FRED ALGER MANAGEMENT, LLC | 2,136,612 | $369,848,000 | 0.96% |